NEW YORK, NY / ACCESS Newswire / August 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Evolent Health, Inc. ("Evolent Health, Inc.") (NYSE:EVH) concerning possible violations of federal securities laws. On August 8, 2025, Evolent issued a press release announcing second quarter revenue results that were below analysts’ […]
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / If you suffered a loss on your Capricor Therapeutics, Inc. (NASDAQ:CAPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/capricor-therapeutics-inc-lawsuit-submission-form-2?prid=161980&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
FREMONT, CA / ACCESS Newswire / August 18, 2025 / Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that it will participate in the 6th Annual Needham Virtual Semiconductor and SemiCap 1×1 Conference on Wednesday, August 20, 2025. Aehr Test President and CEO Gayn Erickson and CFO Chris
(TSX:MATR),(OTC US:MTTRF),(Other OTC:MTTRF), TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) — Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced the appointment of Jane Skoblo as a director of the Company effective August 13, 2025. Ms. Skoblo will serve on both the Audit and Compensation & Organizational Development Committees of Mattr. Ms. Skoblo's addition to the
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sabre Corporation ("Sabre Corporation") (NASDAQ:SABR) concerning possible violations of federal securities laws. On August 7, 2025, Sabre announced disappointing second quarter results, missing revenue and earnings projections, and cutting its guidance for
– Bristol Myers Squibb, Merck & Company, and GE Healthcare Technologies continue advancing the cancer care ecosystem through cutting-edge therapeutics and diagnostic innovations – Personalized and targeted cancer therapies are showing unprecedented promise, with novel approaches potentially revolutionizing how we treat and detect cancer – Propanc Biopharma emerges as a compelling early stage play with
DeFi Technologies Inc. (the “Company” or “DeFi Technologies”) (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance, today announced the launch of the DeFi Technologies Insights Symposium, with the inaugural session to take place in Frankfurt, Germany, on September 25, 2025. https://mma.prnewswire.com/media/2752315/DeFi_Technologies_Inc__DeFi_Technologies_Announces_Inaugural_Ins.jpg The
Provides SGX945 Seven Years of U.S. Market Exclusivity Upon FDA Approval Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Office of Orphan Products Development of the United States (U.S.) Food
BitMine Crypto Holdings Exceed $6.612 billion, including 1.52 million ETH Tokens BitMine Crypto holdings of $6.6 billion ETH is a $1.7 billion increase from $4.9 billion reported last week BitMine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, and Galaxy Digital
Mattr Appoints New Director GlobeNewswire August 18, 2025 TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) — Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced the appointment of Jane Skoblo as a director of the Company effective August 13, 2025. Ms. Skoblo will serve on both the Audit and Compensation & Organizational Development Committees of Mattr.